and the potential launch or commercialization of any of Companys product candidates or products and our strategic and product development objectives and goals, and the other factors discussed under the caption Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2024 and Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, filed with the Securities and Exchange Commission on August 12, 2025 and in our other filings with the SEC
Every batch of Melanotan I undergoes rigorous HPLC-MS quality testing to verify purity, identity, and reproducibility giving researchers the confidence required for accurate and controlled laboratory experiments
Mounjaro should always be stored, used, and disposed of safely to keep your treatment effective and hygienic
From there the voluntary muscle activity was recorded from the most caudal pair of electrodes, followed by measurement and recording of the average motor unit potential (UMP) and the compound motor action potential (CMAP)
Its first generic, abiraterone acetate, launched at a 64 percent discount compared to other generics, saving patients nearly $1,000 annually
